 |
 Video: What is a Stock Split?
|
|
|
| Ardelyx is a biopharmaceutical company focused on discovering, developing and commercializing medicines. This includes adult patients with irritable bowel syndrome with constipation (IBS-C), adult patients with chronic kidney disease (CKD) on dialysis suffering from elevated serum phosphorus, or hyperphosphatemia; and adult patients with CKD and/or heart failure with elevated serum potassium, or hyperkalemia. Co.'s product pipeline includes among other, IBSRELA, a sodium hydrogen exchanger 3 inhibitor for the treatment of IBS-C in adults; and XPHOZAH, which is a medicine being developed for the control of serum phosphorus in adult patients with CKD on dialysis. According to our Ardelyx stock split history records, Ardelyx has had 0 splits. | |
|
Ardelyx (ARDX) has 0 splits in our Ardelyx stock split history database.
Looking at the Ardelyx stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Ardelyx shares, starting with a $10,000 purchase of ARDX, presented on a split-history-adjusted basis factoring in the complete Ardelyx stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/20/2014 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$14.31 |
|
| End price/share: |
$6.42 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-55.14% |
|
| Average Annual Total Return: |
-7.81% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,486.11 |
|
| Years: |
9.86 |
|
|
|
|
|
